Literature DB >> 9236734

The detection and consequences of anxiety in clinical depression.

J Fawcett1.   

Abstract

Anxiety symptoms and comorbid anxiety are common in depressive syndromes, and there is evidence they are associated with increased severity of depression and a poorer outcome. Anxiety and agitation symptoms also appear to be an acute risk factor for suicide in patients who have major affective disorder, an observation that has been supported by a number of biological correlates. Rapid and aggressive treatment of these anxiety/agitation symptoms with suitable antidepressants or benzodiazepines should be considered in order to avoid the immediate risk of suicide and to permit successful treatment of the affective disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236734

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

Review 1.  Comorbidity of depression and anxiety in the elderly.

Authors:  Eric J Lenze
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

2.  fMRI activation in late-life anxious depression: a potential biomarker.

Authors:  Carmen Andreescu; Meryl Butters; Eric J Lenze; Vijay K Venkatraman; Megan Nable; Charles F Reynolds; Howard J Aizenstein
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

3.  High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression.

Authors:  Carmen Andreescu; Eric J Lenze; Benoit H Mulsant; Julie Loebach Wetherell; Amy E Begley; Sati Mazumdar; Charles F Reynolds
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

4.  A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction.

Authors:  Robert L. Barkin; Philip N. Chor; Bennett G. Braun; William A. Schwer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-10

Review 5.  Anxiety symptoms in elderly patients with depression: what is the best approach to treatment?

Authors:  Eric J Lenze; Benoit H Mulsant; M Katherine Shear; Patricia Houck; Charles F Reynolds III
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Clarifying the causal relationship in women between childhood sexual abuse and lifetime major depression.

Authors:  K S Kendler; S H Aggen
Journal:  Psychol Med       Date:  2013-08-13       Impact factor: 7.723

7.  Anxiety and stress in the postpartum: is there more to postnatal distress than depression?

Authors:  Renée L Miller; Julie F Pallant; Lisa M Negri
Journal:  BMC Psychiatry       Date:  2006-03-24       Impact factor: 3.630

8.  Anxiety symptoms and suicidal thoughts and behaviors among patients with mood disorders.

Authors:  Marsal Sanches; Linh K Nguyen; Tong Han Chung; Paul Nestadt; Holly C Wilcox; William H Coryell; Jair C Soares; Sudhakar Selvaraj
Journal:  J Affect Disord       Date:  2022-03-22       Impact factor: 6.533

9.  Venlafaxine extended release (XR) in the treatment of panic disorder.

Authors:  Kevin Kjernisted; Diane McIntosh
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.

Authors:  James A Blumenthal; Michael A Babyak; Wade Edward Craighead; Jonathan Davidson; Alan Hinderliter; Benson Hoffman; Pudugramam Murali Doraiswamy; Andrew Sherwood
Journal:  Depress Anxiety       Date:  2020-08-12       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.